Cisplatin is one of the most active drugs in anticancer therapy, and it is currently used for the treatment of a wide range of cancers, in particular advanced ones. After its introduction in clinical therapy, the research in this field has focused on the preparation of new metal complexes with increased activity and lower side-effects. Besides, the use of drug combinations with synergistic effect, i.e. an effect greater than the sum of the effects of the single drugs, has been introduced. This thesis is focused on the preparation of Cu(II) and Pt(II) complexes and on the study of their cytotoxic properties, alone or in combination with cisplatin. Cu(II) complexes with 1,10-phenantroline (phen), 1,10-phenantrolin-5,6-dione and 1,10- phenantrolin-5,6-diol, with 1:1 or 1:2 metal:ligand stoichiometry, have been synthesized. In addition, mixed Cu(II) complexes with phen and thiophene derivatives of general formula [Cu(phen)2(T)](ClO4)2 (T=1-methylthio-thiophene-2-carboxylic acid, 2- methylthio-thiophene-1-carboxylic acid, 2-thiophenecarboxamide, 2- thiophenecarboxylate) have been prepared. A family of Pt(II) complexes of general formula [Pt(P)(D)2](ClO4)2, being P a derivative of phen and D a derivative of imidazolidin-2-thione, has been synthesized. In order to find the species present in solution in conditions similar to the physiological ones (37 °C and NaCl 0.1 M), the formation constants of the complexes have been determined through potentiometric titrations. The dipole moments of the platinum complexes have been determined through quantum mechanical calculations. The in vitro cytotoxic activity of ligands and metal complexes has been evaluated against a panel of human tumour cell lines, and it has been correlated to their structures. Finally, a new method, based on experimental design and artificial neural networks, has been proposed for the evaluation of the synergy in mixtures of two or more drugs. Exploiting this method, the cytotoxic activity of mixture of cisplatin and three Cu(II) complexes ([Cu(phen)(H2O)2(ClO4)2], [Cu(phen)2(H2O)](ClO4)2 e [Cu(phen)2(imidazolidin-2-thione)](ClO4)2) has been studied, and the combination with higher synergistic effect have been identified.

Studio di complessi di rame (II) e platino (II) con proprietà antitumorali

TRUDU, FEDERICA
2015-03-13

Abstract

Cisplatin is one of the most active drugs in anticancer therapy, and it is currently used for the treatment of a wide range of cancers, in particular advanced ones. After its introduction in clinical therapy, the research in this field has focused on the preparation of new metal complexes with increased activity and lower side-effects. Besides, the use of drug combinations with synergistic effect, i.e. an effect greater than the sum of the effects of the single drugs, has been introduced. This thesis is focused on the preparation of Cu(II) and Pt(II) complexes and on the study of their cytotoxic properties, alone or in combination with cisplatin. Cu(II) complexes with 1,10-phenantroline (phen), 1,10-phenantrolin-5,6-dione and 1,10- phenantrolin-5,6-diol, with 1:1 or 1:2 metal:ligand stoichiometry, have been synthesized. In addition, mixed Cu(II) complexes with phen and thiophene derivatives of general formula [Cu(phen)2(T)](ClO4)2 (T=1-methylthio-thiophene-2-carboxylic acid, 2- methylthio-thiophene-1-carboxylic acid, 2-thiophenecarboxamide, 2- thiophenecarboxylate) have been prepared. A family of Pt(II) complexes of general formula [Pt(P)(D)2](ClO4)2, being P a derivative of phen and D a derivative of imidazolidin-2-thione, has been synthesized. In order to find the species present in solution in conditions similar to the physiological ones (37 °C and NaCl 0.1 M), the formation constants of the complexes have been determined through potentiometric titrations. The dipole moments of the platinum complexes have been determined through quantum mechanical calculations. The in vitro cytotoxic activity of ligands and metal complexes has been evaluated against a panel of human tumour cell lines, and it has been correlated to their structures. Finally, a new method, based on experimental design and artificial neural networks, has been proposed for the evaluation of the synergy in mixtures of two or more drugs. Exploiting this method, the cytotoxic activity of mixture of cisplatin and three Cu(II) complexes ([Cu(phen)(H2O)2(ClO4)2], [Cu(phen)2(H2O)](ClO4)2 e [Cu(phen)2(imidazolidin-2-thione)](ClO4)2) has been studied, and the combination with higher synergistic effect have been identified.
13-mar-2015
Copper complexes
cisplatin
cytotoxic activity
multi-drug therapy
platinum complexes
File in questo prodotto:
File Dimensione Formato  
PhD_Thesis_Trudu.pdf

accesso aperto

Tipologia: Tesi di dottorato
Dimensione 28.03 MB
Formato Adobe PDF
28.03 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/266557
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact